Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1996 Oct;9(4):469–488. doi: 10.1128/cmr.9.4.469

Virulence factors of medically important fungi.

L H Hogan 1, B S Klein 1, S M Levitz 1
PMCID: PMC172905  PMID: 8894347

Abstract

Human fungal pathogens have become an increasingly important medical problem with the explosion in the number of immunocompromised patients as a result of cancer, steroid therapy, chemotherapy, and AIDS. Additionally, the globalization of travel and expansion of humankind into previously undisturbed habitats have led to the reemergence of old fungi and new exposure to previously undescribed fungi. Until recently, relatively little was known about virulence factors for the medically important fungi. With the advent of molecular genetics, rapid progress has now been made in understanding the basis of pathogenicity for organisms such as Aspergillus species and Cryptococcus neoformans. The twin technologies of genetic transformation and "knockout" deletion construction allowed for genetic tests of virulence factors in these organisms. Such knowledge will prove invaluable for the rational design of antifungal therapies. Putative virulence factors and attributes are reviewed for Aspergillus species, C. neoformans, the dimorphic fungal pathogens, and others, with a focus upon a molecular genetic approach. Candida species are excluded from coverage, having been the subject of numerous recent reviews. This growing body of knowledge about fungal pathogens and their virulence factors will significantly aid efforts to treat the serious diseases they cause.

Full Text

The Full Text of this article is available as a PDF (365.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe F., Inaba H., Katoh T., Hotchi M. Effects of iron and desferrioxamine on Rhizopus infection. Mycopathologia. 1990 May;110(2):87–91. doi: 10.1007/BF00446996. [DOI] [PubMed] [Google Scholar]
  2. Abe F., Shibuya H., Tateyama M., Ommura Y., Azumi N., Kimura K. Mucormycosis in diabetic ketoacidosis. Role of unbound iron binding capacity of transferrin. Acta Pathol Jpn. 1986 Oct;36(10):1507–1512. doi: 10.1111/j.1440-1827.1986.tb02822.x. [DOI] [PubMed] [Google Scholar]
  3. Annaix V., Bouchara J. P., Larcher G., Chabasse D., Tronchin G. Specific binding of human fibrinogen fragment D to Aspergillus fumigatus conidia. Infect Immun. 1992 May;60(5):1747–1755. doi: 10.1128/iai.60.5.1747-1755.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Aoki S., Ito-Kuwa S., Nakamura K., Kato J., Ninomiya K., Vidotto V. Extracellular proteolytic activity of Cryptococcus neoformans. Mycopathologia. 1994 Dec;128(3):143–150. doi: 10.1007/BF01138475. [DOI] [PubMed] [Google Scholar]
  5. Arnold W. N., Mann L. C., Garrison R. G. Media-induced departures from the usual, temperature-dependent cell shapes of Sporothrix schenckii and concomitant changes in the acid phosphatase isoenzyme patterns. Microbios. 1987;52(212-213):161–171. [PubMed] [Google Scholar]
  6. Arnold W. N., Mann L. C., Sakai K. H., Garrison R. G., Coleman P. D. Acid phosphatases of Sporothrix schenckii. J Gen Microbiol. 1986 Dec;132(12):3421–3432. doi: 10.1099/00221287-132-12-3421. [DOI] [PubMed] [Google Scholar]
  7. Arnold W. N., Sakai K. H., Mann L. C. Selective inactivation of an extra-cytoplasmic acid phosphatase of yeast-like cells of Sporothrix schenckii by sodium fluoride. J Gen Microbiol. 1987 Jun;133(6):1503–1509. doi: 10.1099/00221287-133-6-1503. [DOI] [PubMed] [Google Scholar]
  8. Arruda L. K., Mann B. J., Chapman M. D. Selective expression of a major allergen and cytotoxin, Asp f I, in Aspergillus fumigatus. Implications for the immunopathogenesis of Aspergillus-related diseases. J Immunol. 1992 Nov 15;149(10):3354–3359. [PubMed] [Google Scholar]
  9. Bauer J., Gareis M., Bott A., Gedek B. Isolation of a mycotoxin (gliotoxin) from a bovine udder infected with Aspergillus fumigatus. J Med Vet Mycol. 1989;27(1):45–50. doi: 10.1080/02681218980000061. [DOI] [PubMed] [Google Scholar]
  10. Beachey E. H. Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J Infect Dis. 1981 Mar;143(3):325–345. doi: 10.1093/infdis/143.3.325. [DOI] [PubMed] [Google Scholar]
  11. Bhattacharjee A. K., Bennett J. E., Glaudemans C. P. Capsular polysaccharides of Cryptococcus neoformans. Rev Infect Dis. 1984 Sep-Oct;6(5):619–624. doi: 10.1093/clinids/6.5.619. [DOI] [PubMed] [Google Scholar]
  12. Blackstock R., McCormack J. M., Hall N. K. Induction of a macrophage-suppressive lymphokine by soluble cryptococcal antigens and its association with models of immunologic tolerance. Infect Immun. 1987 Jan;55(1):233–239. doi: 10.1128/iai.55.1.233-239.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Blasi E., Barluzzi R., Mazzolla R., Tancini B., Saleppico S., Puliti M., Pitzurra L., Bistoni F. Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line. J Neuroimmunol. 1995 Apr;58(1):111–116. doi: 10.1016/0165-5728(95)00016-u. [DOI] [PubMed] [Google Scholar]
  14. Boelaert J. R., Van Cutsem J., de Locht M., Schneider Y. J., Crichton R. R. Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. Kidney Int. 1994 Mar;45(3):667–671. doi: 10.1038/ki.1994.89. [DOI] [PubMed] [Google Scholar]
  15. Boelaert J. R., de Locht M., Van Cutsem J., Kerrels V., Cantinieaux B., Verdonck A., Van Landuyt H. W., Schneider Y. J. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest. 1993 May;91(5):1979–1986. doi: 10.1172/JCI116419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bolaños B., Mitchell T. G. Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum. J Leukoc Biol. 1989 Dec;46(6):521–528. doi: 10.1002/jlb.46.6.521. [DOI] [PubMed] [Google Scholar]
  17. Bradsher R. W. Blastomycosis. Clin Infect Dis. 1992 Mar;14 (Suppl 1):S82–S90. doi: 10.1093/clinids/14.supplement_1.s82. [DOI] [PubMed] [Google Scholar]
  18. Braithwaite A. W., Eichner R. D., Waring P., Müllbacher A. The immunomodulating agent gliotoxin causes genomic DNA fragmentation. Mol Immunol. 1987 Jan;24(1):47–55. doi: 10.1016/0161-5890(87)90110-6. [DOI] [PubMed] [Google Scholar]
  19. Brass C., Volkmann C. M., Klein H. P., Halde C. J., Archibald R. W., Stevens D. A. Pathogen factors and host factors in murine pulmonary blastomycosis. Mycopathologia. 1982 Jun 18;78(3):129–140. doi: 10.1007/BF00466066. [DOI] [PubMed] [Google Scholar]
  20. Brass C., Volkmann C. M., Philpott D. E., Klein H. P., Halde C. J., Stevens D. A. Spontaneous mutant of Blastomyces dermatitidis attenuated in virulence for mice. Sabouraudia. 1982 Jun;20(2):145–158. [PubMed] [Google Scholar]
  21. Breen J. F., Lee I. C., Vogel F. R., Friedman H. Cryptococcal capsular polysaccharide-induced modulation of murine immune responses. Infect Immun. 1982 Apr;36(1):47–51. doi: 10.1128/iai.36.1.47-51.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Brummer E., Castaneda E., Restrepo A. Paracoccidioidomycosis: an update. Clin Microbiol Rev. 1993 Apr;6(2):89–117. doi: 10.1128/cmr.6.2.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Brummer E., Morozumi P. A., Philpott D. E., Stevens D. A. Virulence of fungi: correlation of virulence of Blastomyces dermatitidis in vivo with escape from macrophage inhibition of replication in vitro. Infect Immun. 1981 May;32(2):864–871. doi: 10.1128/iai.32.2.864-871.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Brummer E., Restrepo A., Hanson L. H., Stevens D. A. Virulence of Paracoccidiodes brasiliensis: the influence of in vitro passage and storage. Mycopathologia. 1990 Jan;109(1):13–17. doi: 10.1007/BF00437001. [DOI] [PubMed] [Google Scholar]
  25. Calderone R. A., Braun P. C. Adherence and receptor relationships of Candida albicans. Microbiol Rev. 1991 Mar;55(1):1–20. doi: 10.1128/mr.55.1.1-20.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Calderone R. A. Recognition between Candida albicans and host cells. Trends Microbiol. 1993 May;1(2):55–58. doi: 10.1016/0966-842x(93)90033-n. [DOI] [PubMed] [Google Scholar]
  27. Calderone R. Molecular pathogenesis of fungal infections. Trends Microbiol. 1994 Dec;2(12):461–463. doi: 10.1016/0966-842x(94)90647-5. [DOI] [PubMed] [Google Scholar]
  28. Calderone R., Sturtevant J. Macrophage interactions with Candida. Immunol Ser. 1994;60:505–515. [PubMed] [Google Scholar]
  29. Camargo Z. P., Unterkircher C., Travassos L. R. Identification of antigenic polypeptides of Paracoccidioides brasiliensis by immunoblotting. J Med Vet Mycol. 1989;27(6):407–412. [PubMed] [Google Scholar]
  30. Cameron M. L., Granger D. L., Matthews T. J., Weinberg J. B. Human immunodeficiency virus (HIV)-infected human blood monocytes and peritoneal macrophages have reduced anticryptococcal activity whereas HIV-infected alveolar macrophages retain normal activity. J Infect Dis. 1994 Jul;170(1):60–67. doi: 10.1093/infdis/170.1.60. [DOI] [PubMed] [Google Scholar]
  31. Carlin J. M., Weller J. B. Potentiation of interferon-mediated inhibition of Chlamydia infection by interleukin-1 in human macrophage cultures. Infect Immun. 1995 May;63(5):1870–1875. doi: 10.1128/iai.63.5.1870-1875.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Casadevall A., Scharff M. D. The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies. J Exp Med. 1991 Jul 1;174(1):151–160. doi: 10.1084/jem.174.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Castaneda E., Brummer E., Pappagianis D., Stevens D. A. Chronic pulmonary and disseminated paracoccidioidomycosis in mice: quantitation of progression and chronicity. J Med Vet Mycol. 1987 Dec;25(6):377–387. doi: 10.1080/02681218780000461. [DOI] [PubMed] [Google Scholar]
  34. Chang Y. C., Kwon-Chung K. J. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol. 1994 Jul;14(7):4912–4919. doi: 10.1128/mcb.14.7.4912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Chaudhary B., Singh B. Role of endotoxin of Aspergillus fumigatus in its pathogenicity. Mykosen. 1983 Aug;26(8):430–434. [PubMed] [Google Scholar]
  36. Cherniak R., Morris L. C., Belay T., Spitzer E. D., Casadevall A. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect Immun. 1995 May;63(5):1899–1905. doi: 10.1128/iai.63.5.1899-1905.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Cherniak R., Sundstrom J. B. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun. 1994 May;62(5):1507–1512. doi: 10.1128/iai.62.5.1507-1512.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Chuck S. L., Sande M. A. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med. 1989 Sep 21;321(12):794–799. doi: 10.1056/NEJM198909213211205. [DOI] [PubMed] [Google Scholar]
  39. Clemons K. V., Feldman D., Stevens D. A. Influence of oestradiol on protein expression and methionine utilization during morphogenesis of Paracoccidioides brasiliensis. J Gen Microbiol. 1989 Jun;135(6):1607–1617. doi: 10.1099/00221287-135-6-1607. [DOI] [PubMed] [Google Scholar]
  40. Cohen M. S., Isturiz R. E., Malech H. L., Root R. K., Wilfert C. M., Gutman L., Buckley R. H. Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med. 1981 Jul;71(1):59–66. doi: 10.1016/0002-9343(81)90259-x. [DOI] [PubMed] [Google Scholar]
  41. Cole G. T., Kirkland T. N., Sun S. H. An immunoreactive, water-soluble conidial wall fraction of Coccidioides immitis. Infect Immun. 1987 Mar;55(3):657–667. doi: 10.1128/iai.55.3.657-667.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Cole G. T., Zhu S. W., Hsu L. L., Kruse D., Seshan K. R., Wang F. Isolation and expression of a gene which encodes a wall-associated proteinase of Coccidioides immitis. Infect Immun. 1992 Feb;60(2):416–427. doi: 10.1128/iai.60.2.416-427.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Cole G. T., Zhu S. W., Pan S. C., Yuan L., Kruse D., Sun S. H. Isolation of antigens with proteolytic activity from Coccidioides immitis. Infect Immun. 1989 May;57(5):1524–1534. doi: 10.1128/iai.57.5.1524-1534.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Coles F. B., Schuchat A., Hibbs J. R., Kondracki S. F., Salkin I. F., Dixon D. M., Chang H. G., Duncan R. A., Hurd N. J., Morse D. L. A multistate outbreak of sporotrichosis associated with sphagnum moss. Am J Epidemiol. 1992 Aug 15;136(4):475–487. doi: 10.1093/oxfordjournals.aje.a116521. [DOI] [PubMed] [Google Scholar]
  45. Collins H. L., Bancroft G. J. Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses. Infect Immun. 1991 Nov;59(11):3883–3888. doi: 10.1128/iai.59.11.3883-3888.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Coulot P., Bouchara J. P., Renier G., Annaix V., Planchenault C., Tronchin G., Chabasse D. Specific interaction of Aspergillus fumigatus with fibrinogen and its role in cell adhesion. Infect Immun. 1994 Jun;62(6):2169–2177. doi: 10.1128/iai.62.6.2169-2177.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Cox R. A., Best G. K. Cell wall composition of two strains of Blastomyces dermatitidis exhibiting differences in virulence for mice. Infect Immun. 1972 Apr;5(4):449–453. doi: 10.1128/iai.5.4.449-453.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Cox R. A., Mills L. R., Best G. K., Denton J. F. Histologic reactions to cell walls of an avirulent and a virulent strain of Blastomyces dermatitidis. J Infect Dis. 1974 Feb;129(2):179–186. doi: 10.1093/infdis/129.2.179. [DOI] [PubMed] [Google Scholar]
  49. Cross C. E., Bancroft G. J. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect Immun. 1995 Jul;63(7):2604–2611. doi: 10.1128/iai.63.7.2604-2611.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Currie B. P., Casadevall A. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin Infect Dis. 1994 Dec;19(6):1029–1033. doi: 10.1093/clinids/19.6.1029. [DOI] [PubMed] [Google Scholar]
  51. Cutler J. E., Kanbe T. Antigenic variability of Candida albicans cell surface. Curr Top Med Mycol. 1993;5:27–47. [PubMed] [Google Scholar]
  52. Cutler J. E. Putative virulence factors of Candida albicans. Annu Rev Microbiol. 1991;45:187–218. doi: 10.1146/annurev.mi.45.100191.001155. [DOI] [PubMed] [Google Scholar]
  53. DISALVO A. F., DENTON J. F. LIPID CONTENT OF FOUR STRAINS OF BLASTOMYCES DERMATITIDIS OF DIFFERENT MOUSE VIRULENCE. J Bacteriol. 1963 Apr;85:927–931. doi: 10.1128/jb.85.4.927-931.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Daly A. L., Velazquez L. A., Bradley S. F., Kauffman C. A. Mucormycosis: association with deferoxamine therapy. Am J Med. 1989 Oct;87(4):468–471. doi: 10.1016/s0002-9343(89)80836-8. [DOI] [PubMed] [Google Scholar]
  55. Denning D. W., Ward P. N., Fenelon L. E., Benbow E. W. Lack of vessel wall elastolysis in human invasive pulmonary aspergillosis. Infect Immun. 1992 Dec;60(12):5153–5156. doi: 10.1128/iai.60.12.5153-5156.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Devi S. J., Schneerson R., Egan W., Ulrich T. J., Bryla D., Robbins J. B., Bennett J. E. Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity. Infect Immun. 1991 Oct;59(10):3700–3707. doi: 10.1128/iai.59.10.3700-3707.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Diamond R. D., Bennett J. E. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med. 1974 Feb;80(2):176–181. doi: 10.7326/0003-4819-80-2-176. [DOI] [PubMed] [Google Scholar]
  58. Diamond R. D., Clark R. A. Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro. Infect Immun. 1982 Nov;38(2):487–495. doi: 10.1128/iai.38.2.487-495.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Diamond R. D. Inhibition of monocyte-mediated damage to fungal hyphae by steroid hormones. J Infect Dis. 1983 Jan;147(1):160–160. doi: 10.1093/infdis/147.1.160. [DOI] [PubMed] [Google Scholar]
  60. Diamond R. D., Krzesicki R., Epstein B., Jao W. Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis. Am J Pathol. 1978 May;91(2):313–328. [PMC free article] [PubMed] [Google Scholar]
  61. Diamond R. D., Root R. K., Bennett J. E. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. J Infect Dis. 1972 Apr;125(4):367–376. doi: 10.1093/infdis/125.4.367. [DOI] [PubMed] [Google Scholar]
  62. Dinauer M. C. The respiratory burst oxidase and the molecular genetics of chronic granulomatous disease. Crit Rev Clin Lab Sci. 1993;30(4):329–369. doi: 10.3109/10408369309082591. [DOI] [PubMed] [Google Scholar]
  63. Dixon D. M., Migliozzi J., Cooper C. R., Jr, Solis O., Breslin B., Szaniszlo P. J. Melanized and non-melanized multicellular form mutants of Wangiella dermatitidis in mice: mortality and histopathology studies. Mycoses. 1992 Jan-Feb;35(1-2):17–21. doi: 10.1111/j.1439-0507.1992.tb00814.x. [DOI] [PubMed] [Google Scholar]
  64. Dixon D. M., Polak-Wyss A. The medically important dematiaceous fungi and their identification. Mycoses. 1991 Jan-Feb;34(1-2):1–18. doi: 10.1111/j.1439-0507.1991.tb00613.x. [DOI] [PubMed] [Google Scholar]
  65. Dixon D. M., Polak A., Conner G. W. Mel- mutants of Wangiella dermatitidis in mice: evaluation of multiple mouse and fungal strains. J Med Vet Mycol. 1989;27(5):335–341. [PubMed] [Google Scholar]
  66. Dixon D. M., Polak A., Szaniszlo P. J. Pathogenicity and virulence of wild-type and melanin-deficient Wangiella dermatitidis. J Med Vet Mycol. 1987 Apr;25(2):97–106. doi: 10.1080/02681218780000141. [DOI] [PubMed] [Google Scholar]
  67. Domer J. E. Monosaccharide and chitin content of cell walls of Histoplasma capsulatum and Blastomyces dermatitidis. J Bacteriol. 1971 Sep;107(3):870–877. doi: 10.1128/jb.107.3.870-877.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Dong Z. M., Murphy J. W. Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion. Infect Immun. 1995 Jul;63(7):2632–2644. doi: 10.1128/iai.63.7.2632-2644.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Dromer F., Charreire J., Contrepois A., Carbon C., Yeni P. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect Immun. 1987 Mar;55(3):749–752. doi: 10.1128/iai.55.3.749-752.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Drutz D. J., Huppert M. Coccidioidomycosis: factors affecting the host-parasite interaction. J Infect Dis. 1983 Mar;147(3):372–390. doi: 10.1093/infdis/147.3.372. [DOI] [PubMed] [Google Scholar]
  71. Drutz D. J., Huppert M., Sun S. H., McGuire W. L. Human sex hormones stimulate the growth and maturation of Coccidioides immitis. Infect Immun. 1981 May;32(2):897–907. doi: 10.1128/iai.32.2.897-907.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Duncan R. A., von Reyn C. F., Alliegro G. M., Toossi Z., Sugar A. M., Levitz S. M. Idiopathic CD4+ T-lymphocytopenia--four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med. 1993 Feb 11;328(6):393–398. doi: 10.1056/NEJM199302113280604. [DOI] [PubMed] [Google Scholar]
  73. Duncan R. L., Jr, Artis W. M. Fungistatic capacity of sera from guinea pigs injected with various iron solutions: differences between Trichophyton mentagrophytes and Rhizopus oryzae. Infect Immun. 1982 Jan;35(1):368–370. doi: 10.1128/iai.35.1.368-370.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Eichner R. D., Al Salami M., Wood P. R., Müllbacher A. The effect of gliotoxin upon macrophage function. Int J Immunopharmacol. 1986;8(7):789–797. doi: 10.1016/0192-0561(86)90016-0. [DOI] [PubMed] [Google Scholar]
  75. Eissenberg L. G., Goldman W. E. Histoplasma variation and adaptive strategies for parasitism: new perspectives on histoplasmosis. Clin Microbiol Rev. 1991 Oct;4(4):411–421. doi: 10.1128/cmr.4.4.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Eissenberg L. G., Goldman W. E., Schlesinger P. H. Histoplasma capsulatum modulates the acidification of phagolysosomes. J Exp Med. 1993 Jun 1;177(6):1605–1611. doi: 10.1084/jem.177.6.1605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Eissenberg L. G., Schlesinger P. H., Goldman W. E. Phagosome-lysosome fusion in P388D1 macrophages infected with Histoplasma capsulatum. J Leukoc Biol. 1988 Jun;43(6):483–491. doi: 10.1002/jlb.43.6.483. [DOI] [PubMed] [Google Scholar]
  78. Eissenberg L. G., West J. L., Woods J. P., Goldman W. E. Infection of P388D1 macrophages and respiratory epithelial cells by Histoplasma capsulatum: selection of avirulent variants and their potential role in persistent histoplasmosis. Infect Immun. 1991 May;59(5):1639–1646. doi: 10.1128/iai.59.5.1639-1646.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Ellis D. H., Pfeiffer T. J. Ecology, life cycle, and infectious propagule of Cryptococcus neoformans. Lancet. 1990 Oct 13;336(8720):923–925. doi: 10.1016/0140-6736(90)92283-n. [DOI] [PubMed] [Google Scholar]
  80. Ellis W. O., Smith J. P., Simpson B. K., Oldham J. H. Aflatoxins in food: occurrence, biosynthesis, effects on organisms, detection, and methods of control. Crit Rev Food Sci Nutr. 1991;30(4):403–439. doi: 10.1080/10408399109527551. [DOI] [PubMed] [Google Scholar]
  81. Emery H. S., Shelburne C. P., Bowman J. P., Fallon P. G., Schulz C. A., Jacobson E. S. Genetic study of oxygen resistance and melanization in Cryptococcus neoformans. Infect Immun. 1994 Dec;62(12):5694–5697. doi: 10.1128/iai.62.12.5694-5697.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Falkow S. Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S274–S276. doi: 10.1093/cid/10.supplement_2.s274. [DOI] [PubMed] [Google Scholar]
  83. Feldman D., Do Y., Burshell A., Stathis P., Loose D. S. An estrogen-binding protein and endogenous ligand in Saccharomyces cerevisiae: possible hormone receptor system. Science. 1982 Oct 15;218(4569):297–298. doi: 10.1126/science.6289434. [DOI] [PubMed] [Google Scholar]
  84. Figueiredo F., Alves L. M., Silva C. L. Tumour necrosis factor production in vivo and in vitro in response to Paracoccidioides brasiliensis and the cell wall fractions thereof. Clin Exp Immunol. 1993 Aug;93(2):189–194. doi: 10.1111/j.1365-2249.1993.tb07964.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Frey C. L., Drutz D. J. Influence of fungal surface components on the interaction of Coccidioides immitis with polymorphonuclear neutrophils. J Infect Dis. 1986 May;153(5):933–943. doi: 10.1093/infdis/153.5.933. [DOI] [PubMed] [Google Scholar]
  86. Fromtling R. A., Shadomy H. J., Jacobson E. S. Decreased virulence in stable, acapsular mutants of cryptococcus neoformans. Mycopathologia. 1982 Jul 23;79(1):23–29. doi: 10.1007/BF00636177. [DOI] [PubMed] [Google Scholar]
  87. Frosco M. B., Chase T., Jr, Macmillan J. D. The effect of elastase-specific monoclonal and polyclonal antibodies on the virulence of Aspergillus fumigatus in immunocompromised mice. Mycopathologia. 1994 Feb;125(2):65–76. doi: 10.1007/BF01371095. [DOI] [PubMed] [Google Scholar]
  88. Galgiani J. N. Inhibition of different phases of Coccidioides immitis by human neutrophils or hydrogen peroxide. J Infect Dis. 1986 Feb;153(2):217–222. doi: 10.1093/infdis/153.2.217. [DOI] [PubMed] [Google Scholar]
  89. Granger D. L., Perfect J. R., Durack D. T. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J Clin Invest. 1985 Aug;76(2):508–516. doi: 10.1172/JCI112000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Griffin F. M., Jr Roles of macrophage Fc and C3b receptors in phagocytosis of immunologically coated Cryptococcus neoformans. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3853–3857. doi: 10.1073/pnas.78.6.3853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Hallak J., San-Blas F., San-Blas G. Isolation and wall analysis of dimorphic mutants of Paracoccidioides brasiliensis. Sabouraudia. 1982 Mar;20(1):51–62. doi: 10.1080/00362178285380081. [DOI] [PubMed] [Google Scholar]
  92. Harrison T. S., Kornfeld H., Levitz S. M. The effect of infection with human immunodeficiency virus on the anticryptococcal activity of lymphocytes and monocytes. J Infect Dis. 1995 Sep;172(3):665–671. doi: 10.1093/infdis/172.3.665. [DOI] [PubMed] [Google Scholar]
  93. Hermanowski-Vosatka A., Detmers P. A., Götze O., Silverstein S. C., Wright S. D. Clustering of ligand on the surface of a particle enhances adhesion to receptor-bearing cells. J Biol Chem. 1988 Nov 25;263(33):17822–17827. [PubMed] [Google Scholar]
  94. Hilmarsdottir I., Meynard J. L., Rogeaux O., Guermonprez G., Datry A., Katlama C., Brücker G., Coutellier A., Danis M., Gentilini M. Disseminated Penicillium marneffei infection associated with human immunodeficiency virus: a report of two cases and a review of 35 published cases. J Acquir Immune Defic Syndr. 1993 May;6(5):466–471. [PubMed] [Google Scholar]
  95. Hiruma M., Kagawa S. Effects of hyperthermia on phagocytosis and intracellular killing of Sporothrix schenckii by polymorphonuclear leukocytes. Mycopathologia. 1986 Aug;95(2):93–100. doi: 10.1007/BF00437167. [DOI] [PubMed] [Google Scholar]
  96. Hiruma M., Yamaji K., Shimizu T., Ohata H., Kukita A. Ultrastructural study of tissue reaction of mice against Sporothrix schenckii infection. Arch Dermatol Res. 1988;280 (Suppl):S94–100. [PubMed] [Google Scholar]
  97. Hogan L. H., Josvai S., Klein B. S. Genomic cloning, characterization, and functional analysis of the major surface adhesin WI-1 on Blastomyces dermatitidis yeasts. J Biol Chem. 1995 Dec 22;270(51):30725–30732. doi: 10.1074/jbc.270.51.30725. [DOI] [PubMed] [Google Scholar]
  98. Hogan L. H., Klein B. S. Altered expression of surface alpha-1,3-glucan in genetically related strains of Blastomyces dermatitidis that differ in virulence. Infect Immun. 1994 Aug;62(8):3543–3546. doi: 10.1128/iai.62.8.3543-3546.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Hostetter M. K. Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin Microbiol Rev. 1994 Jan;7(1):29–42. doi: 10.1128/cmr.7.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Houpt D. C., Pfrommer G. S., Young B. J., Larson T. A., Kozel T. R. Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan. Infect Immun. 1994 Jul;62(7):2857–2864. doi: 10.1128/iai.62.7.2857-2864.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Huffnagle G. B., Chen G. H., Curtis J. L., McDonald R. A., Strieter R. M., Toews G. B. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J Immunol. 1995 Oct 1;155(7):3507–3516. [PubMed] [Google Scholar]
  102. Hunninghake G. W., Davidson J. M., Rennard S., Szapiel S., Gadek J. E., Crystal R. G. Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema. Science. 1981 May 22;212(4497):925–927. doi: 10.1126/science.7233186. [DOI] [PubMed] [Google Scholar]
  103. Hurst S. F., Kaufman L. Western immunoblot analysis and serologic characterization of Blastomyces dermatitidis yeast form extracellular antigens. J Clin Microbiol. 1992 Dec;30(12):3043–3049. doi: 10.1128/jcm.30.12.3043-3049.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Ikeda R., Jacobson E. S. Heterogeneity of phenol oxidases in Cryptococcus neoformans. Infect Immun. 1992 Sep;60(9):3552–3555. doi: 10.1128/iai.60.9.3552-3555.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Ikeda R., Shinoda T., Morita T., Jacobson E. S. Characterization of a phenol oxidase from Cryptococcus neoformans var. neoformans. Microbiol Immunol. 1993;37(10):759–764. doi: 10.1111/j.1348-0421.1993.tb01702.x. [DOI] [PubMed] [Google Scholar]
  106. Jacobson E. S., Ayers D. J., Harrell A. C., Nicholas C. C. Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans. J Bacteriol. 1982 Jun;150(3):1292–1296. doi: 10.1128/jb.150.3.1292-1296.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Jacobson E. S., Emery H. S. Catecholamine uptake, melanization, and oxygen toxicity in Cryptococcus neoformans. J Bacteriol. 1991 Jan;173(1):401–403. doi: 10.1128/jb.173.1.401-403.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Jacobson E. S., Emery H. S. Temperature regulation of the cryptococcal phenoloxidase. J Med Vet Mycol. 1991;29(2):121–124. doi: 10.1080/02681219180000201. [DOI] [PubMed] [Google Scholar]
  109. Jacobson E. S., Hove E., Emery H. S. Antioxidant function of melanin in black fungi. Infect Immun. 1995 Dec;63(12):4944–4945. doi: 10.1128/iai.63.12.4944-4945.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Jacobson E. S., Tingler M. J., Quynn P. L. Effect of hypertonic solutes upon the polysaccharide capsule in Cryptococcus neoformans. Mycoses. 1989 Jan;32(1):14–23. doi: 10.1111/j.1439-0507.1989.tb02163.x. [DOI] [PubMed] [Google Scholar]
  111. Jacobson E. S., Tinnell S. B. Antioxidant function of fungal melanin. J Bacteriol. 1993 Nov;175(21):7102–7104. doi: 10.1128/jb.175.21.7102-7104.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Jacobson E. S., Vartivarian S. E. Iron assimilation in Cryptococcus neoformans. J Med Vet Mycol. 1992;30(6):443–450. [PubMed] [Google Scholar]
  113. Johnson S. M., Pappagianis D. The coccidioidal complement fixation and immunodiffusion-complement fixation antigen is a chitinase. Infect Immun. 1992 Jul;60(7):2588–2592. doi: 10.1128/iai.60.7.2588-2592.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Kanetsuna F. Ultrastructural studies on the dimorphism of Paracoccidioides brasiliensis, Blastomyces dermatitidis and Histoplasma capsulatum. Sabouraudia. 1981 Dec;19(4):275–286. doi: 10.1080/00362178185380451. [DOI] [PubMed] [Google Scholar]
  115. Kashino S. S., Singer-Vermes L. M., Calich V. L., Burger E. Alterations in the pathogenicity of one Paracoccidioides brasiliensis isolate do not correlative with its in vitro growth. Mycopathologia. 1990 Sep;111(3):173–180. doi: 10.1007/BF02282801. [DOI] [PubMed] [Google Scholar]
  116. Kaufman L., Standard P. G., Weeks R. J., Padhye A. A. Detection of two Blastomyces dermatitidis serotypes by exoantigen analysis. J Clin Microbiol. 1983 Jul;18(1):110–114. doi: 10.1128/jcm.18.1.110-114.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Kerr I. B., Schaeffer G. V., Miranda D. S. Sex hormones and susceptibility of the rat to paracoccidioidomycosis. Mycopathologia. 1984 Dec 30;88(2-3):149–154. doi: 10.1007/BF00436446. [DOI] [PubMed] [Google Scholar]
  118. Khoo S. H., Denning D. W. Invasive aspergillosis in patients with AIDS. Clin Infect Dis. 1994 Aug;19 (Suppl 1):S41–S48. doi: 10.1093/clinids/19.supplement_1.s41. [DOI] [PubMed] [Google Scholar]
  119. Kirkland T. N., Zhu S. W., Kruse D., Hsu L. L., Seshan K. R., Cole G. T. Coccidioides immitis fractions which are antigenic for immune T lymphocytes. Infect Immun. 1991 Nov;59(11):3952–3961. doi: 10.1128/iai.59.11.3952-3961.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Klein B. S., Chaturvedi S., Hogan L. H., Jones J. M., Newman S. L. Altered expression of surface protein WI-1 in genetically related strains of Blastomyces dermatitidis that differ in virulence regulates recognition of yeasts by human macrophages. Infect Immun. 1994 Aug;62(8):3536–3542. doi: 10.1128/iai.62.8.3536-3542.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Klein B. S., Hogan L. H., Jones J. M. Immunologic recognition of a 25-amino acid repeat arrayed in tandem on a major antigen of Blastomyces dermatitidis. J Clin Invest. 1993 Jul;92(1):330–337. doi: 10.1172/JCI116571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Klein B. S., Jones J. M. Isolation, purification, and radiolabeling of a novel 120-kD surface protein on Blastomyces dermatitidis yeasts to detect antibody in infected patients. J Clin Invest. 1990 Jan;85(1):152–161. doi: 10.1172/JCI114406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Klein B. S., Jones J. M. Purification and characterization of the major antigen WI-1 from Blastomyces dermatitidis yeasts and immunological comparison with A antigen. Infect Immun. 1994 Sep;62(9):3890–3900. doi: 10.1128/iai.62.9.3890-3900.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Klein B. S., Sondel P. M., Jones J. M. WI-1, a novel 120-kilodalton surface protein on Blastomyces dermatitidis yeast cells, is a target antigen of cell-mediated immunity in human blastomycosis. Infect Immun. 1992 Oct;60(10):4291–4300. doi: 10.1128/iai.60.10.4291-4300.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Klein B. S., Vergeront J. M., Davis J. P. Epidemiologic aspects of blastomycosis, the enigmatic systemic mycosis. Semin Respir Infect. 1986 Mar;1(1):29–39. [PubMed] [Google Scholar]
  126. Klimpel K. R., Goldman W. E. Cell walls from avirulent variants of Histoplasma capsulatum lack alpha-(1,3)-glucan. Infect Immun. 1988 Nov;56(11):2997–3000. doi: 10.1128/iai.56.11.2997-3000.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Klimpel K. R., Goldman W. E. Isolation and characterization of spontaneous avirulent variants of Histoplasma capsulatum. Infect Immun. 1987 Mar;55(3):528–533. doi: 10.1128/iai.55.3.528-533.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Kolattukudy P. E., Lee J. D., Rogers L. M., Zimmerman P., Ceselski S., Fox B., Stein B., Copelan E. A. Evidence for possible involvement of an elastolytic serine protease in aspergillosis. Infect Immun. 1993 Jun;61(6):2357–2368. doi: 10.1128/iai.61.6.2357-2368.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Korytowski W., Kalyanaraman B., Menon I. A., Sarna T., Sealy R. C. Reaction of superoxide anions with melanins: electron spin resonance and spin trapping studies. Biochim Biophys Acta. 1986 Jun 19;882(2):145–153. doi: 10.1016/0304-4165(86)90149-2. [DOI] [PubMed] [Google Scholar]
  130. Kothary M. H., Chase T., Jr, Macmillan J. D. Correlation of elastase production by some strains of Aspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice. Infect Immun. 1984 Jan;43(1):320–325. doi: 10.1128/iai.43.1.320-325.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Kozel T. R., Cazin J. Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide. Infect Immun. 1971 Feb;3(2):287–294. doi: 10.1128/iai.3.2.287-294.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Kozel T. R., Gotschlich E. C. The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J Immunol. 1982 Oct;129(4):1675–1680. [PubMed] [Google Scholar]
  133. Kozel T. R., Pfrommer G. S. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast. Infect Immun. 1986 Apr;52(1):1–5. doi: 10.1128/iai.52.1.1-5.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Kozel T. R., Pfrommer G. S., Guerlain A. S., Highison B. A., Highison G. J. Role of the capsule in phagocytosis of Cryptococcus neoformans. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S436–S439. doi: 10.1093/cid/10.supplement_2.s436. [DOI] [PubMed] [Google Scholar]
  135. Kozel T. R., Wilson M. A., Farrell T. P., Levitz S. M. Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae. Infect Immun. 1989 Nov;57(11):3412–3417. doi: 10.1128/iai.57.11.3412-3417.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Kozel T. R., Wilson M. A., Murphy J. W. Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans. Infect Immun. 1991 Sep;59(9):3101–3110. doi: 10.1128/iai.59.9.3101-3110.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Kruse D., Cole G. T. A seroreactive 120-kilodalton beta-1,3-glucanase of Coccidioides immitis which may participate in spherule morphogenesis. Infect Immun. 1992 Oct;60(10):4350–4363. doi: 10.1128/iai.60.10.4350-4363.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Kwon-Chung K. J., Bennett J. E. Distribution of alpha and alpha mating types of Cryptococcus neoformans among natural and clinical isolates. Am J Epidemiol. 1978 Oct;108(4):337–340. doi: 10.1093/oxfordjournals.aje.a112628. [DOI] [PubMed] [Google Scholar]
  139. Kwon-Chung K. J. Comparison of isolates of Sporothrix schenckii obtained from fixed cutaneous lesions with isolates from other types of lesions. J Infect Dis. 1979 Apr;139(4):424–431. doi: 10.1093/infdis/139.4.424. [DOI] [PubMed] [Google Scholar]
  140. Kwon-Chung K. J., Edman J. C., Wickes B. L. Genetic association of mating types and virulence in Cryptococcus neoformans. Infect Immun. 1992 Feb;60(2):602–605. doi: 10.1128/iai.60.2.602-605.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Kwon-Chung K. J., Hill W. B., Bennett J. E. New, special stain for histopathological diagnosis of cryptococcosis. J Clin Microbiol. 1981 Feb;13(2):383–387. doi: 10.1128/jcm.13.2.383-387.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Kwon-Chung K. J. Phylogenetic spectrum of fungi that are pathogenic to humans. Clin Infect Dis. 1994 Aug;19 (Suppl 1):S1–S7. doi: 10.1093/clinids/19.supplement_1.s1. [DOI] [PubMed] [Google Scholar]
  143. Kwon-Chung K. J., Polacheck I., Popkin T. J. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol. 1982 Jun;150(3):1414–1421. doi: 10.1128/jb.150.3.1414-1421.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Kwon-Chung K. J., Rhodes J. C. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Immun. 1986 Jan;51(1):218–223. doi: 10.1128/iai.51.1.218-223.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Kwon-Chung K. J., Tom W. K., Costa J. L. Utilization of indole compounds by Cryptococcus neoformans to produce a melanin-like pigment. J Clin Microbiol. 1983 Dec;18(6):1419–1421. doi: 10.1128/jcm.18.6.1419-1421.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Kwon-Chung K. J., Wickes B. L., Stockman L., Roberts G. D., Ellis D., Howard D. H. Virulence, serotype, and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii. Infect Immun. 1992 May;60(5):1869–1874. doi: 10.1128/iai.60.5.1869-1874.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. LITTMAN M. L., TSUBURA E. Effect of degree of encapsulation upon virulence of Cryptococcus neoformans. Proc Soc Exp Biol Med. 1959 Aug-Sep;101:773–777. doi: 10.3181/00379727-101-25090. [DOI] [PubMed] [Google Scholar]
  148. Lamy B., Moutaouakil M., Latge J. P., Davies J. Secretion of a potential virulence factor, a fungal ribonucleotoxin, during human aspergillosis infections. Mol Microbiol. 1991 Jul;5(7):1811–1815. doi: 10.1111/j.1365-2958.1991.tb01930.x. [DOI] [PubMed] [Google Scholar]
  149. Lane T. E., Otero G. C., Wu-Hsieh B. A., Howard D. H. Expression of inducible nitric oxide synthase by stimulated macrophages correlates with their antihistoplasma activity. Infect Immun. 1994 Apr;62(4):1478–1479. doi: 10.1128/iai.62.4.1478-1479.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Lane T. E., Wu-Hsieh B. A., Howard D. H. Gamma interferon cooperates with lipopolysaccharide to activate mouse splenic macrophages to an antihistoplasma state. Infect Immun. 1993 Apr;61(4):1468–1473. doi: 10.1128/iai.61.4.1468-1473.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Lane T. E., Wu-Hsieh B. A., Howard D. H. Iron limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages. Infect Immun. 1991 Jul;59(7):2274–2278. doi: 10.1128/iai.59.7.2274-2278.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Larcher G., Bouchara J. P., Annaix V., Symoens F., Chabasse D., Tronchin G. Purification and characterization of a fibrinogenolytic serine proteinase from Aspergillus fumigatus culture filtrate. FEBS Lett. 1992 Aug 10;308(1):65–69. doi: 10.1016/0014-5793(92)81052-n. [DOI] [PubMed] [Google Scholar]
  153. Latgé J. P., Moutaouakil M., Debeaupuis J. P., Bouchara J. P., Haynes K., Prévost M. C. The 18-kilodalton antigen secreted by Aspergillus fumigatus. Infect Immun. 1991 Aug;59(8):2586–2594. doi: 10.1128/iai.59.8.2586-2594.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Lei P. C., Yoshiike T., Ogawa H. Effects of proteinase inhibitors on the cutaneous lesion of Sporothrix schenckii inoculated hairless mice. Mycopathologia. 1993 Aug;123(2):81–85. doi: 10.1007/BF01365084. [DOI] [PubMed] [Google Scholar]
  155. Levitz S. M. Aspergillosis. Infect Dis Clin North Am. 1989 Mar;3(1):1–18. [PubMed] [Google Scholar]
  156. Levitz S. M., DiBenedetto D. J. Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans. Infect Immun. 1988 Oct;56(10):2544–2551. doi: 10.1128/iai.56.10.2544-2551.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Levitz S. M., DiBenedetto D. J. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans. J Immunol. 1989 Jan 15;142(2):659–665. [PubMed] [Google Scholar]
  158. Levitz S. M., Diamond R. D. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J Infect Dis. 1985 Nov;152(5):938–945. doi: 10.1093/infdis/152.5.938. [DOI] [PubMed] [Google Scholar]
  159. Levitz S. M., Diamond R. D. Mechanisms of resistance of Aspergillus fumigatus Conidia to killing by neutrophils in vitro. J Infect Dis. 1985 Jul;152(1):33–42. doi: 10.1093/infdis/152.1.33. [DOI] [PubMed] [Google Scholar]
  160. Levitz S. M., Farrell T. P. Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines. Infect Immun. 1990 May;58(5):1201–1209. doi: 10.1128/iai.58.5.1201-1209.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Levitz S. M., Farrell T. P. Human neutrophil degranulation stimulated by Aspergillus fumigatus. J Leukoc Biol. 1990 Feb;47(2):170–175. doi: 10.1002/jlb.47.2.170. [DOI] [PubMed] [Google Scholar]
  162. Levitz S. M., Farrell T. P., Maziarz R. T. Killing of Cryptococcus neoformans by human peripheral blood mononuclear cells stimulated in culture. J Infect Dis. 1991 May;163(5):1108–1113. doi: 10.1093/infdis/163.5.1108. [DOI] [PubMed] [Google Scholar]
  163. Levitz S. M. Macrophage-Cryptococcus interactions. Immunol Ser. 1994;60:533–543. [PubMed] [Google Scholar]
  164. Levitz S. M., Selsted M. E., Ganz T., Lehrer R. I., Diamond R. D. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J Infect Dis. 1986 Sep;154(3):483–489. doi: 10.1093/infdis/154.3.483. [DOI] [PubMed] [Google Scholar]
  165. Levitz S. M., Tabuni A. Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin. J Clin Invest. 1991 Feb;87(2):528–535. doi: 10.1172/JCI115027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Levitz S. M., Tabuni A., Kornfeld H., Reardon C. C., Golenbock D. T. Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect Immun. 1994 May;62(5):1975–1981. doi: 10.1128/iai.62.5.1975-1981.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Levitz S. M., Tabuni A., Wagner R., Kornfeld H., Smail E. H. Binding of unopsonized Cryptococcus neoformans by human bronchoalveolar macrophages: inhibition by a large-molecular-size serum component. J Infect Dis. 1992 Oct;166(4):866–873. doi: 10.1093/infdis/166.4.866. [DOI] [PubMed] [Google Scholar]
  168. Levitz S. M. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis. 1991 Nov-Dec;13(6):1163–1169. doi: 10.1093/clinids/13.6.1163. [DOI] [PubMed] [Google Scholar]
  169. Lodge J. K., Jackson-Machelski E., Toffaletti D. L., Perfect J. R., Gordon J. I. Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12008–12012. doi: 10.1073/pnas.91.25.12008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Loose D. S., Feldman D. Characterization of a unique corticosterone-binding protein in Candida albicans. J Biol Chem. 1982 May 10;257(9):4925–4930. [PubMed] [Google Scholar]
  171. Loose D. S., Stover E. P., Restrepo A., Stevens D. A., Feldman D. Estradiol binds to a receptor-like cytosol binding protein and initiates a biological response in Paracoccidioides brasiliensis. Proc Natl Acad Sci U S A. 1983 Dec;80(24):7659–7663. doi: 10.1073/pnas.80.24.7659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Macher A. M., Bennett J. E., Gadek J. E., Frank M. M. Complement depletion in cryptococcal sepsis. J Immunol. 1978 May;120(5):1686–1690. [PubMed] [Google Scholar]
  173. Maresca B., Bennett J., Fonzi W., Hitchcock C. A., Lodge J. K., Williamson P. R. Molecular approaches to identify novel targets for future development of antifungal agents. J Med Vet Mycol. 1994;32 (Suppl 1):287–298. doi: 10.1080/02681219480000911. [DOI] [PubMed] [Google Scholar]
  174. Maresca B., Carratù L., Kobayashi G. S. Morphological transition in the human fungal pathogen Histoplasma capsulatum. Trends Microbiol. 1994 Apr;2(4):110–114. doi: 10.1016/0966-842x(94)90596-7. [DOI] [PubMed] [Google Scholar]
  175. Maresca B., Kobayashi G. Changes in membrane fluidity modulate heat shock gene expression and produced attenuated strains in the dimorphic fungus Histoplasma capsulatum. Arch Med Res. 1993 Autumn;24(3):247–249. [PubMed] [Google Scholar]
  176. Markaryan A., Morozova I., Yu H., Kolattukudy P. E. Purification and characterization of an elastinolytic metalloprotease from Aspergillus fumigatus and immunoelectron microscopic evidence of secretion of this enzyme by the fungus invading the murine lung. Infect Immun. 1994 Jun;62(6):2149–2157. doi: 10.1128/iai.62.6.2149-2157.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. McEwen J. G., Bedoya V., Patiño M. M., Salazar M. E., Restrepo A. Experimental murine paracoccidiodomycosis induced by the inhalation of conidia. J Med Vet Mycol. 1987 Jun;25(3):165–175. doi: 10.1080/02681218780000231. [DOI] [PubMed] [Google Scholar]
  178. Miller M. F., Mitchell T. G. Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect Immun. 1991 Jan;59(1):24–28. doi: 10.1128/iai.59.1.24-28.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Miller R. F., Mitchell D. M. AIDS and the lung: update 1995. 1. Pneumocystis carinii pneumonia. Thorax. 1995 Feb;50(2):191–200. doi: 10.1136/thx.50.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Mitchell T. G., Perfect J. R. Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev. 1995 Oct;8(4):515–548. doi: 10.1128/cmr.8.4.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Mohr J. A., Long H., McKown B. A., Muchmore H. G. In vitro susceptibility of Cryptococcus neoformans to steroids. Sabouraudia. 1972 Jul;10(2):171–172. [PubMed] [Google Scholar]
  182. Mondon P., Thélu J., Lebeau B., Ambroise-Thomas P., Grillot R. Virulence of Aspergillus fumigatus strains investigated by random amplified polymorphic DNA analysis. J Med Microbiol. 1995 Apr;42(4):299–303. doi: 10.1099/00222615-42-4-299. [DOI] [PubMed] [Google Scholar]
  183. Monod M., Paris S., Sarfati J., Jaton-Ogay K., Ave P., Latgé J. P. Virulence of alkaline protease-deficient mutants of Aspergillus fumigatus. FEMS Microbiol Lett. 1993 Jan 1;106(1):39–46. doi: 10.1111/j.1574-6968.1993.tb05932.x. [DOI] [PubMed] [Google Scholar]
  184. Morrison C. J., Stevens D. A. Mechanisms of fungal pathogenicity: correlation of virulence in vivo, susceptibility to killing by polymorphonuclear neutrophils in vitro, and neutrophil superoxide anion induction among Blastomyces dermatitidis isolates. Infect Immun. 1991 Aug;59(8):2744–2749. doi: 10.1128/iai.59.8.2744-2749.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Moser M., Menz G., Blaser K., Crameri R. Recombinant expression and antigenic properties of a 32-kilodalton extracellular alkaline protease, representing a possible virulence factor from Aspergillus fumigatus. Infect Immun. 1994 Mar;62(3):936–942. doi: 10.1128/iai.62.3.936-942.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Moutaouakil M., Monod M., Prévost M. C., Bouchara J. P., Paris S., Latgé J. P. Identification of the 33-kDa alkaline protease of Aspergillus fumigatus in vitro and in vivo. J Med Microbiol. 1993 Nov;39(5):393–399. doi: 10.1099/00222615-39-5-393. [DOI] [PubMed] [Google Scholar]
  187. Mukherjee J., Casadevall A., Scharff M. D. Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J Exp Med. 1993 Apr 1;177(4):1105–1116. doi: 10.1084/jem.177.4.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Mukherjee J., Nussbaum G., Scharff M. D., Casadevall A. Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J Exp Med. 1995 Jan 1;181(1):405–409. doi: 10.1084/jem.181.1.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Murphy J. W., Cozad G. C. Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect Immun. 1972 Jun;5(6):896–901. doi: 10.1128/iai.5.6.896-901.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Murphy J. W. Influence of cryptococcal antigens on cell-mediated immunity. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S432–S435. doi: 10.1093/cid/10.supplement_2.s432. [DOI] [PubMed] [Google Scholar]
  191. Murphy J. W., Moorhead J. W. Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen. J Immunol. 1982 Jan;128(1):276–283. [PubMed] [Google Scholar]
  192. Müllbacher A., Eichner R. D. Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3835–3837. doi: 10.1073/pnas.81.12.3835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Müllbacher A., Waring P., Eichner R. D. Identification of an agent in cultures of Aspergillus fumigatus displaying anti-phagocytic and immunomodulating activity in vitro. J Gen Microbiol. 1985 May;131(5):1251–1258. doi: 10.1099/00221287-131-5-1251. [DOI] [PubMed] [Google Scholar]
  194. Nakamura L. T., Wu-Hsieh B. A., Howard D. H. Recombinant murine gamma interferon stimulates macrophages of the RAW cell line to inhibit intracellular growth of Histoplasma capsulatum. Infect Immun. 1994 Feb;62(2):680–684. doi: 10.1128/iai.62.2.680-684.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Neilson J. B., Fromtling R. A., Bulmer G. S. Cryptococcus neoformans: size range of infectious particles from aerosolized soil. Infect Immun. 1977 Sep;17(3):634–638. doi: 10.1128/iai.17.3.634-638.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Newman S. L., Bullock W. E. Interaction of Histoplasma capsulatum yeasts and conidia with human and animal macrophages. Immunol Ser. 1994;60:517–532. [PubMed] [Google Scholar]
  197. Newman S. L., Chaturvedi S., Klein B. S. The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14. J Immunol. 1995 Jan 15;154(2):753–761. [PubMed] [Google Scholar]
  198. Newman S. L., Gootee L., Brunner G., Deepe G. S., Jr Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest. 1994 Apr;93(4):1422–1429. doi: 10.1172/JCI117119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Newman S. L., Gootee L., Morris R., Bullock W. E. Digestion of Histoplasma capsulatum yeasts by human macrophages. J Immunol. 1992 Jul 15;149(2):574–580. [PubMed] [Google Scholar]
  200. Ng T. T., Robson G. D., Denning D. W. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology. 1994 Sep;140(Pt 9):2475–2479. doi: 10.1099/13500872-140-9-2475. [DOI] [PubMed] [Google Scholar]
  201. Niehaus W. G., Flynn T. Regulation of mannitol biosynthesis and degradation by Cryptococcus neoformans. J Bacteriol. 1994 Feb;176(3):651–655. doi: 10.1128/jb.176.3.651-655.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  202. Oda L. M., Kubelka C. F., Alviano C. S., Travassos L. R. Ingestion of yeast forms of Sporothrix schenckii by mouse peritoneal macrophages. Infect Immun. 1983 Feb;39(2):497–504. doi: 10.1128/iai.39.2.497-504.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. Orendi J. M., Nottet H. S., Visser M. R., Verheul A. F., Snippe H., Verhoef J. Enhancement of HIV-1 replication in peripheral blood mononuclear cells by Cryptococcus neoformans is monocyte-dependent but tumour necrosis factor-independent. AIDS. 1994 Apr;8(4):423–429. doi: 10.1097/00002030-199404000-00003. [DOI] [PubMed] [Google Scholar]
  204. Paris S., Monod M., Diaquin M., Lamy B., Arruda L. K., Punt P. J., Latgé J. P. A transformant of Aspergillus fumigatus deficient in the antigenic cytotoxin ASPFI. FEMS Microbiol Lett. 1993 Jul 15;111(1):31–36. doi: 10.1111/j.1574-6968.1993.tb06357.x. [DOI] [PubMed] [Google Scholar]
  205. Parta M., Chang Y., Rulong S., Pinto-DaSilva P., Kwon-Chung K. J. HYP1, a hydrophobin gene from Aspergillus fumigatus, complements the rodletless phenotype in Aspergillus nidulans. Infect Immun. 1994 Oct;62(10):4389–4395. doi: 10.1128/iai.62.10.4389-4395.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Pendrak M. L., Klotz S. A. Adherence of Candida albicans to host cells. FEMS Microbiol Lett. 1995 Jun 15;129(2-3):103–113. doi: 10.1111/j.1574-6968.1995.tb07566.x. [DOI] [PubMed] [Google Scholar]
  207. Perfect J. R. Cryptococcosis. Infect Dis Clin North Am. 1989 Mar;3(1):77–102. [PubMed] [Google Scholar]
  208. Perfect J. R., Toffaletti D. L., Rude T. H. The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid. Infect Immun. 1993 Oct;61(10):4446–4451. doi: 10.1128/iai.61.10.4446-4451.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Pettoello-Mantovani M., Casadevall A., Kollmann T. R., Rubinstein A., Goldstein H. Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans. Lancet. 1992 Jan 4;339(8784):21–23. doi: 10.1016/0140-6736(92)90142-p. [DOI] [PubMed] [Google Scholar]
  210. Pettoello-Mantovani M., Casadevall A., Smarnworawong P., Goldstein H. Enhancement of HIV type 1 infectivity in vitro by capsular polysaccharide of Cryptococcus neoformans and Haemophilus influenzae. AIDS Res Hum Retroviruses. 1994 Sep;10(9):1079–1087. doi: 10.1089/aid.1994.10.1079. [DOI] [PubMed] [Google Scholar]
  211. Polacheck I., Hearing V. J., Kwon-Chung K. J. Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans. J Bacteriol. 1982 Jun;150(3):1212–1220. doi: 10.1128/jb.150.3.1212-1220.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  212. Polacheck I., Platt Y., Aronovitch J. Catecholamines and virulence of Cryptococcus neoformans. Infect Immun. 1990 Sep;58(9):2919–2922. doi: 10.1128/iai.58.9.2919-2922.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  213. Polacheck I. The discovery of melanin production in Cryptococcus neoformans and its impact on diagnosis and the study of virulence. Zentralbl Bakteriol. 1991 Dec;276(1):120–123. doi: 10.1016/s0934-8840(11)80225-2. [DOI] [PubMed] [Google Scholar]
  214. Polak A. Melanin as a virulence factor in pathogenic fungi. Mycoses. 1990 May;33(5):215–224. doi: 10.1111/myc.1990.33.5.215. [DOI] [PubMed] [Google Scholar]
  215. Powell B. L., Drutz D. J., Huppert M., Sun S. H. Relationship of progesterone- and estradiol-binding proteins in Coccidioides immitis to coccidioidal dissemination in pregnancy. Infect Immun. 1983 May;40(2):478–485. doi: 10.1128/iai.40.2.478-485.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  216. Powell B. L., Drutz D. J. Identification of a high-affinity binder for estradiol and a low-affinity binder for testosterone in Coccidioides immitis. Infect Immun. 1984 Sep;45(3):784–786. doi: 10.1128/iai.45.3.784-786.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  217. Puccia R., Schenkman S., Gorin P. A., Travassos L. R. Exocellular components of Paracoccidioides brasiliensis: identification of a specific antigen. Infect Immun. 1986 Jul;53(1):199–206. doi: 10.1128/iai.53.1.199-206.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  218. Puccia R., Travassos L. R. The 43-kDa glycoprotein from the human pathogen Paracoccidioides brasiliensis and its deglycosylated form: excretion and susceptibility to proteolysis. Arch Biochem Biophys. 1991 Sep;289(2):298–302. doi: 10.1016/0003-9861(91)90475-x. [DOI] [PubMed] [Google Scholar]
  219. Ramesh M. V., Sirakova T., Kolattukudy P. E. Isolation, characterization, and cloning of cDNA and the gene for an elastinolytic serine proteinase from Aspergillus flavus. Infect Immun. 1994 Jan;62(1):79–85. doi: 10.1128/iai.62.1.79-85.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Reichard U., Eiffert H., Rüchel R. Purification and characterization of an extracellular aspartic proteinase from Aspergillus fumigatus. J Med Vet Mycol. 1994 Dec;32(6):427–436. doi: 10.1080/02681219480000581. [DOI] [PubMed] [Google Scholar]
  221. Remaley A. T., Kuhns D. B., Basford R. E., Glew R. H., Kaplan S. S. Leishmanial phosphatase blocks neutrophil O-2 production. J Biol Chem. 1984 Sep 25;259(18):11173–11175. [PubMed] [Google Scholar]
  222. Resnick S., Pappagianis D., McKerrow J. H. Proteinase production by the parasitic cycle of the pathogenic fungus Coccidioides immitis. Infect Immun. 1987 Nov;55(11):2807–2815. doi: 10.1128/iai.55.11.2807-2815.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  223. Restrepo A., Salazar M. E., Cano L. E., Stover E. P., Feldman D., Stevens D. A. Estrogens inhibit mycelium-to-yeast transformation in the fungus Paracoccidioides brasiliensis: implications for resistance of females to paracoccidioidomycosis. Infect Immun. 1984 Nov;46(2):346–353. doi: 10.1128/iai.46.2.346-353.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  224. Rhodes J. C., Amlung T. W., Miller M. S. Isolation and characterization of an elastinolytic proteinase from Aspergillus flavus. Infect Immun. 1990 Aug;58(8):2529–2534. doi: 10.1128/iai.58.8.2529-2534.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  225. Rhodes J. C., Bode R. B., McCuan-Kirsch C. M. Elastase production in clinical isolates of Aspergillus. Diagn Microbiol Infect Dis. 1988 Jul;10(3):165–170. doi: 10.1016/0732-8893(88)90036-3. [DOI] [PubMed] [Google Scholar]
  226. Rhodes J. C., Polacheck I., Kwon-Chung K. J. Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect Immun. 1982 Jun;36(3):1175–1184. doi: 10.1128/iai.36.3.1175-1184.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  227. Richardson M. D., White L. J., McKay I. C., Shankland G. S. Differential binding of acapsulate and encapsulated strains of Cryptococcus neoformans to human neutrophils. J Med Vet Mycol. 1993;31(3):189–199. [PubMed] [Google Scholar]
  228. Robens J. F., Richard J. L. Aflatoxins in animal and human health. Rev Environ Contam Toxicol. 1992;127:69–94. doi: 10.1007/978-1-4613-9751-9_3. [DOI] [PubMed] [Google Scholar]
  229. Robertson M. D., Seaton A., Milne L. J., Raeburn J. A. Resistance of spores of Aspergillus fumigatus to ingestion by phagocytic cells. Thorax. 1987 Jun;42(6):466–472. doi: 10.1136/thx.42.6.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  230. Robertson M. D., Seaton A., Milne L. J., Raeburn J. A. Suppression of host defences by Aspergillus fumigatus. Thorax. 1987 Jan;42(1):19–25. doi: 10.1136/thx.42.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  231. Roos D. The genetic basis of chronic granulomatous disease. Immunol Rev. 1994 Apr;138:121–157. doi: 10.1111/j.1600-065x.1994.tb00850.x. [DOI] [PubMed] [Google Scholar]
  232. Ryter A., Fromentin H. Ultrastructural study of the interaction of the fungi Sporothrix schenckii and Ceratocystis stenoceras with bone-marrow-derived murine macrophages. Ann Inst Pasteur Microbiol. 1985 Jul-Aug;136B(1):9–27. doi: 10.1016/s0769-2609(85)80002-8. [DOI] [PubMed] [Google Scholar]
  233. Salazar M. E., Restrepo A., Stevens D. A. Inhibition by estrogens of conidium-to-yeast conversion in the fungus Paracoccidioides brasiliensis. Infect Immun. 1988 Mar;56(3):711–713. doi: 10.1128/iai.56.3.711-713.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  234. San-Blas F., San-Blas G. Mutants of Paracoccidioides brasiliensis strain IVIC Pb9 affected in dimorphism. J Med Vet Mycol. 1992;30(1):51–60. [PubMed] [Google Scholar]
  235. San-Blas G. Paracoccidioidomycosis and its etiologic agent Paracoccidioides brasiliensis. J Med Vet Mycol. 1993;31(2):99–113. [PubMed] [Google Scholar]
  236. San-Blas G., Restrepo A., Clemons K., Stevens D. A., San-Blas F., Puccia R., Travassos L. R., Figueroa J. I., Hamilton A. J., Bartholomew M. A. Paracoccidioidomycosis. J Med Vet Mycol. 1992;30 (Suppl 1):59–71. doi: 10.1080/02681219280000771. [DOI] [PubMed] [Google Scholar]
  237. San-Blas G., San-Blas F. Paracoccidioides brasiliensis: cell wall structure and virulence. A review. Mycopathologia. 1977 Dec 16;62(2):77–86. doi: 10.1007/BF01259396. [DOI] [PubMed] [Google Scholar]
  238. Sandhu D. K., Sandhu R. S., Khan Z. U., Damodaran V. N. Conditional virulence of a p-aminobenzoic acid-requiring mutant of Aspergillus fumigatus. Infect Immun. 1976 Feb;13(2):527–532. doi: 10.1128/iai.13.2.527-532.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  239. Sano A., Miyaji M., Nishimura K. Studies on the relationship between paracoccidioidomycosis in ddY mice and their estrous cycle. Mycopathologia. 1991 Aug;115(2):73–81. doi: 10.1007/BF00436795. [DOI] [PubMed] [Google Scholar]
  240. Schaffner A., Douglas H., Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest. 1982 Mar;69(3):617–631. doi: 10.1172/JCI110489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  241. Silva C. L., Alves L. M., Figueiredo F. Involvement of cell wall glucans in the genesis and persistence of the inflammatory reaction caused by the fungus Paracoccidioides brasiliensis. Microbiology. 1994 May;140(Pt 5):1189–1194. doi: 10.1099/13500872-140-5-1189. [DOI] [PubMed] [Google Scholar]
  242. Silva C. L., Fazioli R. A. A Paracoccidioides brasiliensis polysaccharide having granuloma-inducing, toxic and macrophage-stimulating activity. J Gen Microbiol. 1985 Jun;131(6):1497–1501. doi: 10.1099/00221287-131-6-1497. [DOI] [PubMed] [Google Scholar]
  243. Silva C. L., Figueiredo F. Tumor necrosis factor in paracoccidioidomycosis patients. J Infect Dis. 1991 Nov;164(5):1033–1034. doi: 10.1093/infdis/164.5.1033. [DOI] [PubMed] [Google Scholar]
  244. Sirakova T. D., Markaryan A., Kolattukudy P. E. Molecular cloning and sequencing of the cDNA and gene for a novel elastinolytic metalloproteinase from Aspergillus fumigatus and its expression in Escherichia coli. Infect Immun. 1994 Oct;62(10):4208–4218. doi: 10.1128/iai.62.10.4208-4218.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  245. Small J. M., Mitchell T. G. Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A. Infect Immun. 1989 Dec;57(12):3751–3756. doi: 10.1128/iai.57.12.3751-3756.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  246. Smith J. M., Davies J. E., Holden D. W. Construction and pathogenicity of Aspergillus fumigatus mutants that do not produce the ribotoxin restrictocin. Mol Microbiol. 1993 Sep;9(5):1071–1077. doi: 10.1111/j.1365-2958.1993.tb01236.x. [DOI] [PubMed] [Google Scholar]
  247. Smith J. M., Tang C. M., Van Noorden S., Holden D. W. Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. Infect Immun. 1994 Dec;62(12):5247–5254. doi: 10.1128/iai.62.12.5247-5254.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  248. Speed B., Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis. 1995 Jul;21(1):28–36. doi: 10.1093/clinids/21.1.28. [DOI] [PubMed] [Google Scholar]
  249. Stevens D. A. The interface of mycology and endocrinology. J Med Vet Mycol. 1989;27(3):133–140. doi: 10.1080/02681218980000191. [DOI] [PubMed] [Google Scholar]
  250. Stover E. P., Schär G., Clemons K. V., Stevens D. A., Feldman D. Estradiol-binding proteins from mycelial and yeast-form cultures of Paracoccidioides brasiliensis. Infect Immun. 1986 Jan;51(1):199–203. doi: 10.1128/iai.51.1.199-203.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  251. Sturtevant J. E., Latgé J. P. Interactions between conidia of Aspergillus fumigatus and human complement component C3. Infect Immun. 1992 May;60(5):1913–1918. doi: 10.1128/iai.60.5.1913-1918.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  252. Sturtevant J., Latgé J. P. Participation of complement in the phagocytosis of the conidia of Aspergillus fumigatus by human polymorphonuclear cells. J Infect Dis. 1992 Sep;166(3):580–586. doi: 10.1093/infdis/166.3.580. [DOI] [PubMed] [Google Scholar]
  253. Sugar A. M. Mucormycosis. Clin Infect Dis. 1992 Mar;14 (Suppl 1):S126–S129. doi: 10.1093/clinids/14.supplement_1.s126. [DOI] [PubMed] [Google Scholar]
  254. Sundstrom J. B., Cherniak R. T-cell-dependent and T-cell-independent mechanisms of tolerance to glucuronoxylomannan of Cryptococcus neoformans serotype A. Infect Immun. 1993 Apr;61(4):1340–1345. doi: 10.1128/iai.61.4.1340-1345.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  255. Sutton P., Newcombe N. R., Waring P., Müllbacher A. In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi. Infect Immun. 1994 Apr;62(4):1192–1198. doi: 10.1128/iai.62.4.1192-1198.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  256. Tang C. M., Cohen J., Holden D. W. An Aspergillus fumigatus alkaline protease mutant constructed by gene disruption is deficient in extracellular elastase activity. Mol Microbiol. 1992 Jun;6(12):1663–1671. doi: 10.1111/j.1365-2958.1992.tb00891.x. [DOI] [PubMed] [Google Scholar]
  257. Tang C. M., Cohen J., Krausz T., Van Noorden S., Holden D. W. The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect Immun. 1993 May;61(5):1650–1656. doi: 10.1128/iai.61.5.1650-1656.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  258. Tang C. M., Smith J. M., Arst H. N., Jr, Holden D. W. Virulence studies of Aspergillus nidulans mutants requiring lysine or p-aminobenzoic acid in invasive pulmonary aspergillosis. Infect Immun. 1994 Dec;62(12):5255–5260. doi: 10.1128/iai.62.12.5255-5260.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  259. Taylor M. W., Feng G. S. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 1991 Aug;5(11):2516–2522. [PubMed] [Google Scholar]
  260. Thau N., Monod M., Crestani B., Rolland C., Tronchin G., Latgé J. P., Paris S. rodletless mutants of Aspergillus fumigatus. Infect Immun. 1994 Oct;62(10):4380–4388. doi: 10.1128/iai.62.10.4380-4388.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  261. Torres-Guererro H., Edman J. C. Melanin-deficient mutants of Cryptococcus neoformans. J Med Vet Mycol. 1994;32(4):303–313. [PubMed] [Google Scholar]
  262. Tronchin G., Bouchara J. P., Annaix V., Robert R., Senet J. M. Fungal cell adhesion molecules in Candida albicans. Eur J Epidemiol. 1991 Jan;7(1):23–33. doi: 10.1007/BF00221338. [DOI] [PubMed] [Google Scholar]
  263. Tronchin G., Bouchara J. P., Larcher G., Lissitzky J. C., Chabasse D. Interaction between Aspergillus fumigatus and basement membrane laminin: binding and substrate degradation. Biol Cell. 1993;77(2):201–208. doi: 10.1016/s0248-4900(05)80189-3. [DOI] [PubMed] [Google Scholar]
  264. Truelsen K., Young T., Kozel T. R. In vivo complement activation and binding of C3 to encapsulated Cryptococcus neoformans. Infect Immun. 1992 Sep;60(9):3937–3939. doi: 10.1128/iai.60.9.3937-3939.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  265. Tsuboi R., Sanada T., Ogawa H. Influence of culture medium pH and proteinase inhibitors on extracellular proteinase activity and cell growth of Sporothrix schenckii. J Clin Microbiol. 1988 Jul;26(7):1431–1433. doi: 10.1128/jcm.26.7.1431-1433.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  266. Tsuboi R., Sanada T., Takamori K., Ogawa H. Isolation and properties of extracellular proteinases from Sporothrix schenckii. J Bacteriol. 1987 Sep;169(9):4104–4109. doi: 10.1128/jb.169.9.4104-4109.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  267. Van Cutsem J., Boelaert J. R. Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis). Kidney Int. 1989 Dec;36(6):1061–1068. doi: 10.1038/ki.1989.301. [DOI] [PubMed] [Google Scholar]
  268. Vartivarian S. E., Anaissie E. J., Cowart R. E., Sprigg H. A., Tingler M. J., Jacobson E. S. Regulation of cryptococcal capsular polysaccharide by iron. J Infect Dis. 1993 Jan;167(1):186–190. doi: 10.1093/infdis/167.1.186. [DOI] [PubMed] [Google Scholar]
  269. Vartivarian S. E., Cowart R. E., Anaissie E. J., Tashiro T., Sprigg H. A. Iron acquisition by Cryptococcus neoformans. J Med Vet Mycol. 1995 May-Jun;33(3):151–156. [PubMed] [Google Scholar]
  270. Vaz C. A., Mackenzie D. W., Hearn V., Camargo Z. P., Singer-Vermes L. M., Burger E., Calich V. L. Gelatinase activity of exoantigens from virulent and non-virulent isolates of Paracoccidioides brasiliensis. J Med Vet Mycol. 1994;32(1):65–69. doi: 10.1080/02681219480000091. [DOI] [PubMed] [Google Scholar]
  271. Vecchiarelli A., Pietrella D., Dottorini M., Monari C., Retini C., Todisco T., Bistoni F. Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages. Clin Exp Immunol. 1994 Nov;98(2):217–223. doi: 10.1111/j.1365-2249.1994.tb06128.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  272. Vecchiarelli A., Retini C., Pietrella D., Monari C., Tascini C., Beccari T., Kozel T. R. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect Immun. 1995 Aug;63(8):2919–2923. doi: 10.1128/iai.63.8.2919-2923.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  273. Verdonck A. K., Boelaert J. R., Gordts B. Z., Van Landuyt H. W. Effect of ferrioxamine on the growth of Rhizopus. Mycoses. 1993 Jan-Feb;36(1-2):9–12. doi: 10.1111/j.1439-0507.1993.tb00680.x. [DOI] [PubMed] [Google Scholar]
  274. Vicentini A. P., Gesztesi J. L., Franco M. F., de Souza W., de Moraes J. Z., Travassos L. R., Lopes J. D. Binding of Paracoccidioides brasiliensis to laminin through surface glycoprotein gp43 leads to enhancement of fungal pathogenesis. Infect Immun. 1994 Apr;62(4):1465–1469. doi: 10.1128/iai.62.4.1465-1469.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  275. Waldorf A. R., Diamond R. D. Cerebral mucormycosis in diabetic mice after intrasinus challenge. Infect Immun. 1984 Apr;44(1):194–195. doi: 10.1128/iai.44.1.194-195.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  276. Waldorf A. R., Diamond R. D. Neutrophil chemotactic responses induced by fresh and swollen Rhizopus oryzae spores and Aspergillus fumigatus conidia. Infect Immun. 1985 May;48(2):458–463. doi: 10.1128/iai.48.2.458-463.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  277. Waldorf A. R., Levitz S. M., Diamond R. D. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis. 1984 Nov;150(5):752–760. doi: 10.1093/infdis/150.5.752. [DOI] [PubMed] [Google Scholar]
  278. Waldorf A. R., Ruderman N., Diamond R. D. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest. 1984 Jul;74(1):150–160. doi: 10.1172/JCI111395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  279. Wang Y., Aisen P., Casadevall A. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect Immun. 1995 Aug;63(8):3131–3136. doi: 10.1128/iai.63.8.3131-3136.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  280. Wang Y., Casadevall A. Decreased susceptibility of melanized Cryptococcus neoformans to UV light. Appl Environ Microbiol. 1994 Oct;60(10):3864–3866. doi: 10.1128/aem.60.10.3864-3866.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  281. Wang Y., Casadevall A. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect Immun. 1994 Jul;62(7):3004–3007. doi: 10.1128/iai.62.7.3004-3007.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  282. Waring P. DNA fragmentation induced in macrophages by gliotoxin does not require protein synthesis and is preceded by raised inositol triphosphate levels. J Biol Chem. 1990 Aug 25;265(24):14476–14480. [PubMed] [Google Scholar]
  283. Waring P., Eichner R. D., Müllbacher A., Sjaarda A. Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties. J Biol Chem. 1988 Dec 5;263(34):18493–18499. [PubMed] [Google Scholar]
  284. Washburn R. G., Bryant-Varela B. J., Julian N. C., Bennett J. E. Differences in Cryptococcus neoformans capsular polysaccharide structure influence assembly of alternative complement pathway C3 convertase on fungal surfaces. Mol Immunol. 1991 Apr-May;28(4-5):465–470. doi: 10.1016/0161-5890(91)90160-l. [DOI] [PubMed] [Google Scholar]
  285. Washburn R. G., DeHart D. J., Agwu D. E., Bryant-Varela B. J., Julian N. C. Aspergillus fumigatus complement inhibitor: production, characterization, and purification by hydrophobic interaction and thin-layer chromatography. Infect Immun. 1990 Nov;58(11):3508–3515. doi: 10.1128/iai.58.11.3508-3515.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  286. Washburn R. G., Hammer C. H., Bennett J. E. Inhibition of complement by culture supernatants of Aspergillus fumigatus. J Infect Dis. 1986 Dec;154(6):944–951. doi: 10.1093/infdis/154.6.944. [DOI] [PubMed] [Google Scholar]
  287. Williamson P. R. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J Bacteriol. 1994 Feb;176(3):656–664. doi: 10.1128/jb.176.3.656-664.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  288. Wong B., Perfect J. R., Beggs S., Wright K. A. Production of the hexitol D-mannitol by Cryptococcus neoformans in vitro and in rabbits with experimental meningitis. Infect Immun. 1990 Jun;58(6):1664–1670. doi: 10.1128/iai.58.6.1664-1670.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  289. Wood G. E. Mycotoxins in foods and feeds in the United States. J Anim Sci. 1992 Dec;70(12):3941–3949. doi: 10.2527/1992.70123941x. [DOI] [PubMed] [Google Scholar]
  290. Woods J. P., Goldman W. E. Autonomous replication of foreign DNA in Histoplasma capsulatum: role of native telomeric sequences. J Bacteriol. 1993 Feb;175(3):636–641. doi: 10.1128/jb.175.3.636-641.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  291. Woods J. P., Goldman W. E. In vivo generation of linear plasmids with addition of telomeric sequences by Histoplasma capsulatum. Mol Microbiol. 1992 Dec;6(23):3603–3610. doi: 10.1111/j.1365-2958.1992.tb01796.x. [DOI] [PubMed] [Google Scholar]
  292. Wright S. D., Ramos R. A., Hermanowski-Vosatka A., Rockwell P., Detmers P. A. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J Exp Med. 1991 May 1;173(5):1281–1286. doi: 10.1084/jem.173.5.1281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  293. Wright S. D., Ramos R. A., Tobias P. S., Ulevitch R. J., Mathison J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990 Sep 21;249(4975):1431–1433. doi: 10.1126/science.1698311. [DOI] [PubMed] [Google Scholar]
  294. Yoshiike T., Lei P. C., Komatsuzaki H., Ogawa H. Antibody raised against extracellular proteinases of Sporothrix schenckii in S. schenckii inoculated hairless mice. Mycopathologia. 1993 Aug;123(2):69–73. doi: 10.1007/BF01365082. [DOI] [PubMed] [Google Scholar]
  295. Young B. J., Kozel T. R. Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans. Infect Immun. 1993 Jul;61(7):2966–2972. doi: 10.1128/iai.61.7.2966-2972.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  296. Yuan L., Cole G. T. Characterization of a proteinase inhibitor isolated from the fungal pathogen Coccidioides immitis. Biochem J. 1989 Feb 1;257(3):729–736. doi: 10.1042/bj2570729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  297. Yuan L., Cole G. T. Isolation and characterization of an extracellular proteinase of Coccidioides immitis. Infect Immun. 1987 Sep;55(9):1970–1978. doi: 10.1128/iai.55.9.1970-1978.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  298. Yuan L., Cole G. T., Sun S. H. Possible role of a proteinase in endosporulation of Coccidioides immitis. Infect Immun. 1988 Jun;56(6):1551–1559. doi: 10.1128/iai.56.6.1551-1559.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  299. Zacharias D., Ueda A., Moscardi-Bacchi M., Franco M., San-Blas G. A comparative histopathological, immunological, and biochemical study of experimental intravenous paracoccidioidomycosis induced in mice by three Paracoccidioides brasiliensis isolates. J Med Vet Mycol. 1986 Dec;24(6):445–454. [PubMed] [Google Scholar]
  300. Zebedee S. L., Koduri R. K., Mukherjee J., Mukherjee S., Lee S., Sauer D. F., Scharff M. D., Casadevall A. Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans. Antimicrob Agents Chemother. 1994 Jul;38(7):1507–1514. doi: 10.1128/aac.38.7.1507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  301. de Albornoz M. B., Mendoza M., de Torres E. D. Growth temperatures of isolates of Sporothrix schenckii from disseminated and fixed cutaneous lesions of sporotrichosis. Mycopathologia. 1986 Aug;95(2):81–83. doi: 10.1007/BF00437165. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES